We are live on
!
Find out more
NFA
Nationwide Fund Advisors Portfolio holdings
AUM
$2.42B
1-Year Est. Return
17.68%
This Fund
S&P 500
This Quarter
Est. Return
+1.62%
1 Year Est. Return
+17.68%
3 Year Est. Return
+28.25%
5 Year Est. Return
+4.07%
10 Year Est. Return
+84.84%
AUM
$23B
AUM Growth
-$294M
(-1.3%)
Cap. Flow
-$302M
Cap. Flow
% of AUM
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
10.05%
Holding
3,336
New
91
Increased
1,121
Reduced
1,460
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$34.1M |
| 2 |
Comcast
CMCSA
|
+$34.1M |
| 3 |
Dentsply Sirona
XRAY
|
+$34.1M |
| 4 |
Baxter International
BAX
|
+$31.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$42.9M |
| 2 |
Cognizant
CTSH
|
+$38.1M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$34.6M |
| 4 |
WEC Energy
WEC
|
+$34.5M |
| 5 |
Amazon
AMZN
|
+$34.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.39% |
| 2 | Healthcare | 13.62% |
| 3 | Financials | 13.32% |
| 4 | Industrials | 11.99% |
| 5 | Consumer Discretionary | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Coherus Oncology
CHRS
$224M
| $328K | ﹤0.01% |
14,732
-715
| -5% | -$11.7K |
|
|
CTWS
2302
DELISTED
Connecticut Water Service Inc
CTWS
| $326K | ﹤0.01% |
7,235
+43
| +0.6% | +$1.79K |
|
|
ALR
2303
DELISTED
AlerisLife Inc
ALR
| $323K | ﹤0.01% |
14,120
| – | – |
|
|
OME
2304
DELISTED
Omega Protein
OME
| $323K | ﹤0.01% |
19,061
-490
| -3% | -$10K |
|
2305
Westlake Corp
WLK
$10.1B
| $321K | ﹤0.01% |
+6,930
| New | +$314K |
|
|
CVT
2306
DELISTED
CVENT, INC.
CVT
| $321K | ﹤0.01% |
14,998
-449
| -3% | -$10.6K |
|
2307
Gorman-Rupp
GRC
$2.25B
| $319K | ﹤0.01% |
12,315
-140
| -1% | -$3.49K |
|
2308
Middlesex Water
MSEX
$1.08B
| $319K | ﹤0.01% |
10,328
-350
| -3% | -$9.92K |
|
2309
Century Aluminum
CENX
$4.64B
| $318K | ﹤0.01% |
43,323
-1,570
| -3% | -$8.7K |
|
|
EPZM
2310
DELISTED
Epizyme, Inc
EPZM
| $317K | ﹤0.01% |
26,156
+6,818
| +35% | +$69K |
|
|
ARNA
2311
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $317K | ﹤0.01% |
15,260
-663
| -4% | -$10.6K |
|
|
IL
2312
DELISTED
IntraLinks Holdings Inc.
IL
| $317K | ﹤0.01% |
40,201
| – | – |
|
2313
Ark Restaurants
ARKR
$20.2M
| $316K | ﹤0.01% |
15,342
| – | – |
|
|
BLT
2314
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $316K | ﹤0.01% |
31,663
+26
| +0.1% | +$249 |
|
2315
National Beverage
FIZZ
$3.02B
| $315K | ﹤0.01% |
14,892
+112
| +0.8% | +$2.22K |
|
|
BDSI
2316
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $315K | ﹤0.01% |
97,454
-2,820
| -3% | -$10.4K |
|
2317
Anterix
ATEX
$1.94B
| $314K | ﹤0.01% |
8,535
| – | – |
|
2318
Liberty Broadband Class C
LBRDK
$5.16B
| $314K | ﹤0.01% |
5,410
-190
| -3% | -$9.55K |
|
|
NPKI
2319
NPK International
NPKI
$1.15B
| $314K | ﹤0.01% |
72,697
-2,817
| -4% | -$12K |
|
2320
Zumiez
ZUMZ
$330M
| $311K | ﹤0.01% |
15,628
-147
| -0.9% | -$2.76K |
|
|
LNW
2321
DELISTED
Light & Wonder
LNW
| $309K | ﹤0.01% |
31,377
-1,631
| -5% | -$12.2K |
|
2322
AtriCure
ATRC
$2B
| $308K | ﹤0.01% |
18,272
-269
| -1% | -$4.73K |
|
|
KERX
2323
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $308K | ﹤0.01% |
65,868
-2,857
| -4% | -$11.4K |
|
2324
Travere Therapeutics
TVTX
$5.84B
| $307K | ﹤0.01% |
22,482
-675
| -3% | -$10.2K |
|
2325
Enanta Pharmaceuticals
ENTA
$384M
| $306K | ﹤0.01% |
10,408
-85
| -0.8% | -$2.37K |
|
Similar funds
PUI
VF
PA
KFA
QT
DSCM
GWM
MAS
Nationwide Fund Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Nationwide Fund Advisors held 3,336 positions worth $23B, down 1.3% from $23.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Nationwide Fund Advisors's Q1 2016 filing shows 91 new, 1,121 increased, 1,460 reduced and 84 closed positions. Its largest new stake was iShares Russell 1000 Growth ETF: 400,000 shares worth $9.98M. The largest sale was Mastercard, an estimated $42.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Nationwide Fund Advisors's largest Q1 2016 buy was iShares Russell 1000 Growth ETF: 400,000 shares worth $9.98M.
- Nationwide Fund Advisors added most to AbbVie in Q1 2016, an estimated $34.1M increase.
- Nationwide Fund Advisors's biggest Q1 2016 reduction was Mastercard, cutting an estimated $42.9M.
- Nationwide Fund Advisors fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $34.6M.
- Nationwide Fund Advisors's ten largest holdings make up 10% of its $23B portfolio in Q1 2016.
- Nationwide Fund Advisors opened 91 new positions and closed 84 in Q1 2016.
- Nationwide Fund Advisors's portfolio value fell 1.3% quarter-over-quarter to $23B.
Based on Nationwide Fund Advisors's 13F filing for Q1 2016, filed 5 May 2016.